Mirae Asset Global Investments Co. Ltd. Has $9.52 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Mirae Asset Global Investments Co. Ltd. increased its stake in HCA Healthcare by 4.9%, now holding 24,837 shares worth approximately $9.52 million.
• HCA Healthcare reported a net income of $6.84 earnings per share for the last quarter, exceeding analysts' expectations, alongside a revenue of $18.61 billion.
• The company declared a quarterly dividend of $0.72 per share, reflecting a 0.7% dividend yield and a low payout ratio of 12.11%.

Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 4.9% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 24,837 shares of the company's stock after acquiring an additional 1,153 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in HCA Healthcare were worth $9,515,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Metropolis Capital Ltd lifted its holdings in HCA Healthcare by 76.6% during the 2nd quarter. Metropolis Capital Ltd now owns 603,029 shares of the company's stock worth $231,020,000 after buying an additional 261,592 shares in the last quarter. Pure Financial Advisors LLC acquired a new position in shares of HCA Healthcare during the second quarter valued at $247,000. Childress Capital Advisors LLC acquired a new stake in HCA Healthcare in the second quarter worth about $232,000. PBMares Wealth Management LLC acquired a new position in HCA Healthcare during the 2nd quarter valued at about $209,000. Finally, Park Place Capital Corp raised its stake in shares of HCA Healthcare by 2,336.0% during the second quarter. Park Place Capital Corp now owns 1,218 shares of the company's stock worth $474,000 after buying an additional 1,168 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Stock Up 0.7%

Shares of HCA stock opened at $429.52 on Monday. The company has a market capitalization of $100.50 billion, a price-to-earnings ratio of 18.05, a P/E/G ratio of 1.35 and a beta of 1.40. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $432.36. The firm has a fifty day moving average of $397.53 and a 200-day moving average of $372.92.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the prior year, the business earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is currently 12.11%.

Wall Street Analyst Weigh In

HCA has been the subject of a number of analyst reports. JPMorgan Chase & Co. lifted their target price on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a report on Monday, August 4th. Weiss Ratings reissued a "buy (b-)" rating on shares of HCA Healthcare in a research note on Saturday, September 27th. Truist Financial boosted their target price on HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research report on Wednesday, July 16th. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Finally, Morgan Stanley reduced their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research report on Monday, July 28th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of "Moderate Buy" and an average target price of $407.75.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 3,836 shares of the firm's stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares of the company's stock, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.